Cactus Inc has a consensus price target of $44.67 based on the ratings of 38 analysis. The 3 most-recent analyst ratings were released by Barclays, B of A Securities, and Stifel on May 6, 2024, April 15, 2024, and January 3, 2024, respectively. With an average price target of $53 between Barclays, B of A Securities, and Stifel, there's an implied 3.66% upside for Cactus Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/06/2024 | Buy Now | 9.52% | Barclays | David Anderson | $55 → $56 | Maintains | Overweight | Get Alert |
05/06/2024 | Buy Now | — | Benchmark | Kurt Hallead | — | Reiterates | → Hold | Get Alert |
04/15/2024 | Buy Now | -15.9% | B of A Securities | Chase Mulvehill | $40 → $43 | Maintains | Underperform | Get Alert |
01/16/2024 | Buy Now | — | Benchmark | Kurt Hallead | — | Downgrade | Buy → Hold | Get Alert |
01/03/2024 | Buy Now | 17.35% | Stifel | Stephen Gengaro | $68 → $60 | Maintains | Buy | Get Alert |
11/14/2023 | Buy Now | 11.48% | Barclays | David Anderson | $60 → $57 | Maintains | Overweight | Get Alert |
11/13/2023 | Buy Now | 7.57% | Piper Sandler | Bill Herbert | $59 → $55 | Maintains | Neutral | Get Alert |
10/17/2023 | Buy Now | — | Barclays | David Anderson | — | Upgrade | Equal-Weight → Overweight | Get Alert |
10/16/2023 | Buy Now | -8.08% | B of A Securities | Chase Mulvehill | $46 → $47 | Downgrade | Neutral → Underperform | Get Alert |
09/13/2023 | Buy Now | 17.35% | JP Morgan | Arun Jayaram | → $60 | Initiates | → Neutral | Get Alert |
08/14/2023 | Buy Now | 15.39% | Piper Sandler | Bill Herbert | $46 → $59 | Maintains | Neutral | Get Alert |
08/10/2023 | Buy Now | -6.12% | Barclays | David Anderson | $46 → $48 | Maintains | Equal-Weight | Get Alert |
08/08/2023 | Buy Now | 17.35% | Benchmark | Kurt Hallead | → $60 | Reiterates | Buy → Buy | Get Alert |
07/18/2023 | Buy Now | 1.7% | Citigroup | Scott Gruber | $40 → $52 | Maintains | Neutral | Get Alert |
05/19/2023 | Buy Now | 19.3% | Stifel | Stephen Gengaro | $64 → $61 | Maintains | Buy | Get Alert |
05/18/2023 | Buy Now | -21.77% | Citigroup | Scott Gruber | $48 → $40 | Maintains | Neutral | Get Alert |
05/16/2023 | Buy Now | 17.35% | Benchmark | Kurt Hallead | → $60 | Reiterates | Buy → Buy | Get Alert |
04/05/2023 | Buy Now | -6.12% | Citigroup | Scott Gruber | $52 → $48 | Maintains | Neutral | Get Alert |
02/28/2023 | Buy Now | 1.7% | Citigroup | Scott Gruber | $60 → $52 | Maintains | Neutral | Get Alert |
02/28/2023 | Buy Now | -10.03% | Barclays | David Anderson | $50 → $46 | Maintains | Equal-Weight | Get Alert |
01/19/2023 | Buy Now | 36.91% | Benchmark | Kurt Hallead | → $70 | Initiates | → Buy | Get Alert |
11/08/2022 | Buy Now | 25.17% | Stifel | Stephen Gengaro | $62 → $64 | Maintains | Buy | Get Alert |
11/08/2022 | Buy Now | 15.39% | B of A Securities | Chase Mulvehill | $45 → $59 | Maintains | Neutral | Get Alert |
10/06/2022 | Buy Now | -6.12% | Barclays | David Anderson | $52 → $48 | Downgrade | Overweight → Equal-Weight | Get Alert |
09/26/2022 | Buy Now | 7.57% | Morgan Stanley | Connor Lynagh | $50 → $55 | Maintains | Equal-Weight | Get Alert |
08/08/2022 | Buy Now | 1.7% | Barclays | David Anderson | $57 → $52 | Maintains | Overweight | Get Alert |
07/13/2022 | Buy Now | -2.21% | Morgan Stanley | Connor Lynagh | $60 → $50 | Maintains | Equal-Weight | Get Alert |
05/09/2022 | Buy Now | 11.48% | Barclays | David Anderson | $56 → $57 | Maintains | Overweight | Get Alert |
04/11/2022 | Buy Now | — | Morgan Stanley | Connor Lynagh | — | Downgrade | Overweight → Equal-Weight | Get Alert |
04/08/2022 | Buy Now | 21.26% | Stifel | Stephen Gengaro | $55 → $62 | Maintains | Buy | Get Alert |
03/11/2022 | Buy Now | — | B of A Securities | Chase Mulvehill | — | Downgrade | Buy → Neutral | Get Alert |
03/02/2022 | Buy Now | 7.57% | Piper Sandler | Ian Macpherson | $45.5 → $55 | Maintains | Neutral | Get Alert |
03/01/2022 | Buy Now | — | Tudor Pickering | Taylor Zurcher | — | Downgrade | Buy → Hold | Get Alert |
02/28/2022 | Buy Now | 7.57% | Stifel | Stephen Gengaro | $54 → $55 | Maintains | Buy | Get Alert |
01/31/2022 | Buy Now | 5.61% | Stifel | Stephen Gengaro | $51 → $54 | Maintains | Buy | Get Alert |
11/11/2021 | Buy Now | -2.21% | Citigroup | — | — | Maintains | Buy | Get Alert |
11/04/2021 | Buy Now | -0.25% | Stifel | Stephen Gengaro | $43 → $51 | Maintains | Buy | Get Alert |
10/25/2021 | Buy Now | -2.21% | Barclays | — | — | Maintains | Overweight | Get Alert |
The latest price target for Cactus (NYSE:WHD) was reported by Barclays on May 6, 2024. The analyst firm set a price target for $56.00 expecting WHD to rise to within 12 months (a possible 9.52% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for Cactus (NYSE:WHD) was provided by Barclays, and Cactus maintained their overweight rating.
The last upgrade for Cactus Inc happened on October 17, 2023 when Barclays raised their price target to N/A. Barclays previously had an equal-weight for Cactus Inc.
The last downgrade for Cactus Inc happened on January 16, 2024 when Benchmark changed their price target from N/A to N/A for Cactus Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cactus, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cactus was filed on May 6, 2024 so you should expect the next rating to be made available sometime around May 6, 2025.
While ratings are subjective and will change, the latest Cactus (WHD) rating was a maintained with a price target of $55.00 to $56.00. The current price Cactus (WHD) is trading at is $51.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.